Can heart checks save Hodgkin's survivors?

NCT ID NCT00165425

Ongoing Knowledge-focused Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether a heart screening program is practical for people who survived Hodgkin's disease after chest radiation. Researchers will use echocardiograms and stress tests to find heart problems early and track risk factors. The goal is to improve care for 210 survivors treated at Dana-Farber Cancer Institute.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to routine heart screening guidelines for Hodgkin's survivors, helping detect heart problems early and improve long-term health.
What could go wrong: This is an observational feasibility study, not a treatment trial. It may not prove that screening improves outcomes, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

classic Hodgkin lymphoma Hodgkins lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HODGKIN'S DISEASE

Contacts and locations

Locations

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Dana-Farber Cancer Institute

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.